Lack of value of procalcitonin for prediction of coronary aneurysms in Kawasaki disease

Pediatric Infectious Disease Journal

Volumn 26, Issue 2, 2007, Pages 179-180

  Catalano Pons, Charlotte ^a   André, Marie Claude ^a   Chalumeau, Martin ^a   Guérin, Sylvie ^b   Gendrel, Dominique ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b Hôpital Cochin ^*  (France)

Author keywords

Coronary aneurysms; Kawasaki disease; Procalcitonin

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ARTICLE; BIOLOGY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DISEASE MARKER; ECHOCARDIOGRAPHY; HOSPITALIZATION; HUMAN; INFANT; LEUKOCYTE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREDICTION; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CHILD; CHILD, PRESCHOOL; CORONARY ANEURYSM; ECHOCARDIOGRAPHY; HUMANS; INFANT; LEUKOCYTE COUNT; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; STATISTICS;

EID: 33846628152     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000250686.70233.8e     Document Type: Article

References (12)

1. Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J. 2000;19:679-688.
2. Gendrel D, Assicot M, Raymond J, et al. Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr. 1996;128:570-573.
3. Okada Y, Minakami H, Tomomasa T, et al. Serum procalcitonin concentration in patients with Kawasaki disease. J Infect. 2004;48:199-205.
4. Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S. Predictors of coronary artery lesions after intravenous-gamma-globulin treatment in Kawasaki disease. J Pediatr. 2000;137:177-180.
5. Koyanagi H, Yanagawa H, Nakamura Y, Yashiro M. Serum C-reactive protein levels in patients with Kawasaki disease: from the results of the nation-wide surveys of Kawasaki disease in Japan. Acta Paediatr. 1997;86:613-619.
6. Lin CY, Lin CC, Hwang B, Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr. 1992;121:924-926.
7. Taubert KA. AHA scientific statement. Diagnostic guidelines for Kawasaki disease. Circulation. 2001;103:335-336.
8. Hatherill M, Tibby SM, Turner C, et al. Procalcitonin and cytokine levels: Relationship to organ failure and mortality in pediatric septic shock. Crit Care Med. 2000;28:2591-2594.
9. Shulman ST, Rowley AH. Etiology and pathogenesis of Kawasaki disease. Progr Pediatr Cardiol. 1997;6:187-192.
10. Leung DYM, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 1993;342:1385-1388.
11. Kikuta H, Sakiyama Y, Matsumoto S, et al. Detection of Epstein-Barr virus DNA in cardiac and aortic tissues from chronic, active Epstein-Barr virus infection associated with Kawasaki disease-like coronary artery aneurysms. J Pediatr. 1993;123:90-92.
12. Catalano-Pons C, Quartier P, Leruez-Ville M, et al. Primary cytomegalovirus infection, atypical Kawasaki disease, and coronary aneurysms in 2 infants. Clin Infect Dis. 2005 1;41:e53-56.